Oral Corticosteroid Relieves Post-COVID-19 Anosmia in a 35-Year-Old Patient
Joint Authors
Touisserkani, Sam K.
Ayatollahi, Azin
Source
Case Reports in Otolaryngology
Issue
Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-2, 2 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2020-08-08
Country of Publication
Egypt
No. of Pages
2
Main Subjects
Abstract EN
Coronavirus disease 2019 (COVID-19) is a highly infectious respiratory illness caused by SARS-CoV-2.
Not much is yet known about this new viral disease.
In our early encounter with the COVID-19, before the pandemic and during the early days of dealing with this novel viral disease in our country, we saw some cases of anosmia in patients infected by SARS-CoV-2.
In many cases, this chemosensitive dysfunction persisted after the negativization of the nasopharyngeal swab.
We report effective treatment of anosmia by oral corticosteroid therapy in a patient recovered from COVID-19.
American Psychological Association (APA)
Touisserkani, Sam K.& Ayatollahi, Azin. 2020. Oral Corticosteroid Relieves Post-COVID-19 Anosmia in a 35-Year-Old Patient. Case Reports in Otolaryngology،Vol. 2020, no. 2020, pp.1-2.
https://search.emarefa.net/detail/BIM-1150248
Modern Language Association (MLA)
Touisserkani, Sam K.& Ayatollahi, Azin. Oral Corticosteroid Relieves Post-COVID-19 Anosmia in a 35-Year-Old Patient. Case Reports in Otolaryngology No. 2020 (2020), pp.1-2.
https://search.emarefa.net/detail/BIM-1150248
American Medical Association (AMA)
Touisserkani, Sam K.& Ayatollahi, Azin. Oral Corticosteroid Relieves Post-COVID-19 Anosmia in a 35-Year-Old Patient. Case Reports in Otolaryngology. 2020. Vol. 2020, no. 2020, pp.1-2.
https://search.emarefa.net/detail/BIM-1150248
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1150248
